Advertisement
Canada markets close in 2 hours 15 minutes
  • S&P/TSX

    21,880.17
    +6.45 (+0.03%)
     
  • S&P 500

    5,043.43
    -28.20 (-0.56%)
     
  • DOW

    38,106.32
    -354.60 (-0.92%)
     
  • CAD/USD

    0.7317
    +0.0019 (+0.26%)
     
  • CRUDE OIL

    82.89
    +0.08 (+0.10%)
     
  • Bitcoin CAD

    88,196.69
    -582.12 (-0.66%)
     
  • CMC Crypto 200

    1,392.76
    +10.19 (+0.74%)
     
  • GOLD FUTURES

    2,342.20
    +3.80 (+0.16%)
     
  • RUSSELL 2000

    1,972.53
    -22.90 (-1.15%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ

    15,577.68
    -135.07 (-0.86%)
     
  • VOLATILITY

    16.37
    +0.40 (+2.50%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6812
    -0.0007 (-0.10%)
     

Why Aurinia Pharmaceuticals Stock Bolted Higher Today

Why Aurinia Pharmaceuticals Stock Bolted Higher Today

Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. Rumors began to swirl about a possible buyout this morning after Novartis (NYSE: NVS) reportedly said during its research and development day that it will focus on smaller bolt-on acquisitions, instead of megadeals. Aurinia has repeatedly been the topic of the buyout rumor mill in 2021.